James C. Knight completed a PhD in chemistry at Cardiff
University in 2009. His research focused on the development of molecular
imaging agents based on lanthanide and transition metal complexes. He then attended Cardiff University (2009–2011), University of Alberta (2011–2013), and University of Oxford (2013–2018) for his postdoctoral fellowship. He is a
lecturer in radiochemistry at the School of Natural and Environmental Sciences
at Newcastle University. He leads a research team that is dedicated to the
synthesis and preclinical evaluation of new radiopharmaceuticals for imaging
and therapeutic applications. He is Head of Admissions (2024–present) for MSc Chemistry and MSc Drug Chemistry programmes, and the lead for radiochemistry within the Discovery of Medicines research theme in the Faculty of Medical Sciences. Previously, he was the Degree Programme Director for MSc Drug Chemistry (2022–24).
James C. Knight completed a PhD in chemistry at Cardiff
University in 2009. His research focused on the development of molecular
imaging agents based on lanthanide and transition metal complexes. He then attended Cardiff University (2009–2011), University of Alberta (2011–2013), and University of Oxford (2013–2018) for his postdoctoral fellowship. He is a
lecturer in radiochemistry at the School of Natural and Environmental Sciences
at Newcastle University. He leads a research team that is dedicated to the
synthesis and preclinical evaluation of new radiopharmaceuticals for imaging
and therapeutic applications. He is Head of Admissions (2024–present) for MSc Chemistry and MSc Drug Chemistry programmes, and the lead for radiochemistry within the Discovery of Medicines research theme in the Faculty of Medical Sciences. Previously, he was the Degree Programme Director for MSc Drug Chemistry (2022–24).